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Objectives: To stratify leg ischaemia into high and low risk groups with respect o outcome. 
Methods:  An evaluation of 20 recent publications, reporting the results of 6118 patients with critical ischaemia. Low 
and high risk patient groups are identified by the definition of critical ischaemia. These groups are analysed with respect 
to outcome of the patient and limb. 
Main outcome measures: Major amputation and mortality. 
Results:  From these data subcritical (rest pain and~or ankle pressure >40 mmHg, n =4089) and critical (tissue loss and/ 
or ankle pressure <40 mmHg, n =2029) risk group of patients was identified. The 1, 3 and 5-year mortality is 26%, 44% 
and 56% with or without reconstruction. For patients in the low risk group, 27% did not lose their leg within the year 
if treated conservatively. For patients in the high risk group, amputation was required by 95% if treated conservatively, 
compared to 25% if treated with arterial reconstruction. 
Conclusion: Reconstructive surgery should be viewed from the following, more realistic, perspective. For patients with 
rest pain (and~or ankle pressure >40 mmHg), 100% cumulative patency is equivalent to 64% resolution of symptoms at 
1 year, as the rest may have improved without treatment. For high risk patients (tissue loss and~or ankle pressure 
<40 mmHg), 100% cumulative patency is equivalent to 93% limb salvage at 1 year. Future reports should identify these 
two groups separately, as the dominant difference between outcome studies is the proportion of subcriticaI patients in the 
study rather than better surgical or radiological techniques. This stratification also has an important bearing on 
pharmacotherapy trials. 
Introduction 
There are enormous discrepancies between the re- 
ported results of arterial reconstruction from different 
centres. Much of this is due to the inappropriate 
inclusion of patients with non-critical limbs into stud- 
ies on chronic critical leg ischaemia. ~ Several defini- 
tions of critical ischaemia have recently been produced, 
all  of which fail to predict eventual outcome with 
any degree of precision. 2 Nevertheless, the definitions 
imply that the outcome depends on the degree of 
ischaemia. 
The natural history of these patients is extremely 
difficult to study, as most undergo some type of inter- 
ventional procedure. Nevertheless, it is apparent that 
in most publications reporting the results of critical 
ischaemia there are two distinct groups with respect 
to outcome. There is a lower risk group consisting of 
patients with rest pain, not always with a low ankle 
pressure (hereafter called subcritical ischaemia). In 
addition, there is a higher risk group consisting of 
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those patients with true limb-threatening disease, i.e. 
those with tissue loss and/or  ankle pressure <40 mmHg 
(hereafter called critical ischaemia (Table 1). 
The aim of this study is to use the definition of 
critical ischaemia (Table 2) and apply it to patients 
obtained from a review of recent publications in order 
to determine the effect of treatment on these patients 
according to the severity of their ischaemia. 
Methods 
Twenty recent publications 1'3~1 containing details of 
6118 patients with "critical ischaemia" have been re- 
viewed (Table 3). All patients have either been treated 
Table 1. Critical ischaemic groups with respect to outcome. 
Group Inclusion criteria 
1. Lower risk Rest pain and 
(subcritical ischaemia) ankle pressure >40 mmHg 
2. High risk Rest pain Tissue loss 
(critical ischaemia) and~or 
ankle pressure <40 mmHg 
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Table 2. Definitions of critical ischaemia. 
1. Fontaine Classification 26
Stage 3 Rest pain caused by arterial disease 
Stage 4 Ulceration and/or gangrene caused by arterial disease 
2. International Vascular Symposium Working Party Definition 24 
1. Severe rest pain requiring opiate analgesia for at least 
4 weeks 
and either: 
2. Ankle pressure <40 mmHg 
or: 
3. Ankle pressure <60 mmHg in the presence of tissue 
necrosis or digital gangrene 
(Diabetics should be excluded from the ideal clinical study) 
3. Modified International Vascular Symposium Working Party Definition 2 
1. Severe rest pain requiring opiate analgesia for at least 
4 weeks 
and either: 
2. Ankle pressure <40 mmHg 
or :  
3. Tissue necrosis or digital gangrene 
4. First European Working Group Definition 25 
1. Severe rest pain requiring opiate analgesia for at least 
2 weeks 
or: 
2. Ulceration or gangrene 
and: 
3. Ankle pressure <50 mmHg 
5. Second European Consensus Document 23 
1. Persistently recurring ischaemic rest pain requiring 
analgesia >2 weeks 
and: 
Ankle systolic pressure <50 mmHg 
and~or; 
Toe systolic pressure <30 mmHg 
or: 
2. Ulceration or gangrene of the foot or toes 
and: 
Ankle systolic pressure <50 mmHg 
or" 
Toe systolic pressure <30 mmHg 
Table 3. Twenty recent critical ischaemia publications (n =6118). 
Author Year No. patients 
Finch 3 1980 145 
Crawford 4 1981 230 
Rush 5 1981 256 
Towne 6 1981 154 
Veith 7 1981 679 
Mosley 9 1986 66 
Jamieson 8 1983 64 
Wolfe 1° 1988 428 
Beard 11 1989 79 
Taylor 12 1990 387 
Dormandy la 1990 Review 
Taylor 14 1991 498 
da Silva is 1993 679 
Thompson 1 1993 148 
Paaske 16 1994 153 
Aune 17 1994 271 
Troeng 18 1994 690 
Schroeder 19 1994 1065 
Currie 2° 1994 50 
Wyatt 21 1994 76 
conservatively, received reconstructive surgery or an- 
gioplasty, or had an amputation. All treatment types 
are considered in the analysis. 
Each paper utilises at least one of the existing defini- 
tions of critical ischaemia (Table 2). These criteria 
are noted when analysing each report, and patients 
defined as either low or high risk dependent upon the 
presence of rest pain or tissue loss or an ankle pressure 
of above or below 40 mmHg respectively (Table 1). 
These low and high risk groups are further analysed 
with respect o patient survival and l imb salvage. True 
life-table analysis requires absolute numbers, and these 
are not presented in most publications. The cal- 
culations in this study are not complex, and each study 
has merely been weighted for patient number  at each 
time point prior to inclusion in patient survival and 
limb salvage calculations. 
For each group we then predicted the outcome of 
critical ischaemia with respect o mortality. In addition, 
the relative benefits of conservative therapy with re- 
spect to resolution of symptoms,  and reconstructive 
surgery with respect o l imb salvage, can be assessed. 
Results 
Data analysis from these 20 studies 1'3-21 reveals a low 
risk group of 4089 patients with rest pain and/or  a high 
ankle pressure (>40 mmHg) ,  subcritical ischaemia, and 
a high risk group of 2029 patients who have either 
tissue loss and/or  a recorded ankle pressure of less 
than 40mmHg (approximate ratio low:high r isk= 
2:1) critical ischaemia. 
Outcome for all 6118 patients included in this study 
is shown in Fig. 1. The 1, 3 and 5-year mortality for 
all patients with critical ischaemia is 26%, 44% and 
56%, respectively. This compares with a 1, 3 and 5- 
year mortality of 5%, 10% and 25% in an age and sex 
matched control group of patients without vascular 
disease. 22 
At 1 year, 73% of patients in the low risk group lost 
their leg or died if treated conservatively (Fig. 1). For 
those patients fitting the high risk criteria, 95% of those 
treated conservatively required amputat ion within a 
year. By comparison, for those high risk patients who 
received reconstruction, only 25% required major am- 
putation. 
From these data, comment can be made on the effect 
of treatment on the natural history of critical ischaemia 
(Fig. 2). For patients in the high risk group, 26% will 
be dead whatever the mode of treatment and 5% will 
not be amputated if treated conservatively. This leaves 
69% alive and potentially improved by intervention 
at 1 year. 
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Fig. 1. Survival of patients with critical ischaemia (n= 6118) compared with an age and sex matched control. (23~ 
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Fig. 2. Pie charts howing outcome of low and high risk critical 
ischaemia patients at 1 year (% patients). 
Mortality data concerning the low risk group is less 
secure due to our inability to obtain a separate 1 year 
mortality for this patient group. Again, 26% of patients 
are dead at 1 year despite treatment. Added to the 
27% whose symptoms would have improved with 
conservative treatment, this leaves 47% potentially 
improved by intervention. 
Discuss ion  
The major purpose of defining and grading ischaemia 
is to clarify the reports and allow reasonable com- 
parison between different studies. Many of the gross 
differences in reported results are due to the inclusion 
of a variable proportion of patients with a grim out- 
look. "Limb salvage" includes an ill-defined melange 
of patients, hence the need for "critical ischaemia'. 
This definition, with all its flaws, has been abused: it 
is impossible for all patients to have either claudication 
or critical ischaemia, since some will have rest pain 
and not meet the definition, yet surgical journals are 
littered with such reports. We therefore set out to 
identify a "low risk group" and a "high risk group" 
of patients with rest pain__ tissue loss. 
High risk patients had rest pain and either tissue 
loss or an ankle pressure <40 mmHg (critical isch- 
aemia). Low risk patients had rest pain, an intact 
foot and an ankle pressure >40 mmHg (subcritical 
ischaemia). 
Data from the Joint Vascular Research Group Study 
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from i6 centres in the United Kingdom summarised 
the outcome of critical leg ischaemia s follows: at 1 
year 20% of patients died, 25% of patients lost one leg 
and only 55% were alive with both legs. 1° The present 
analysis confirms these findings and in addition iden- 
tifies a high risk patient group, in whom only 5% 
survived with an intact limb unless they had successful 
surgical intervention. This supports our prejudice and 
makes it very difficult o perform randomised studies 
to try and predict a group of critically ischaemic limbs 
which might benefit from a less invasive approach. 
It was previously assumed that all patients with 
severe ischaemia would at some stage require a major 
amputation if not treated surgically. Although data 
concerning the natural history for the conservative 
treatment ofcritical ischaemia is sparse, 23 we do know 
that a proportion of these limbs do not progress to 
amputation. In some instances conservative ormedical 
treatment of patients with leg ischaemia may be suf- 
ficient. 
Unfortunately, to date no definition of critical isch- 
aemia provides good enough specificity and sensitivity 
to predict those patients who are at lower risk of 
amputation. 2 The Fontaine classification 26 has been 
more useful than "limb salvage" and subcritical and 
critical ischaemia re similar to Fontaine III and Fon- 
taine IV. There are, however, important differences; it 
has been shown that in a large cohort of patients the 
outcome of rest pain and an ankle pressure <40 mmHg 
(Fontaine III) is similar to rest pain with tissue loss 
(Fonta ine  IV). 2 Critical ischaemia therefore includes 
patients in the most severe category, who would be 
excluded from Fontaine IV. 
In a recent retrospective study of 136 critically isch- 
aemic limbs treated conservatively, the 1-year limb 
salvage rate was 54%. 27 At the same time interval, 
patient survival was 46% and only 25% of all patients 
were alive with both legs. In other words, even if these 
patients had been suitable for intervention, the 1-year 
outcome would only have been improved in 75% of 
patients. Although the current European definition of 
critical ischaemia was used in that study, no higher 
risk group was identified. Indeed, all the current 
definitions of critical ischaemia have been criticised 
for not being able to predict outcome accurately. ~ 
The results of the present analysis go some way 
towards predicting the natural history of patients re- 
ceiving conservative therapy for the treatment of crit- 
ical ischaemia. By applying the criteria of rest pain or 
tissue loss and/or an ankle pressure of above or below 
40mmHg applied retrospectively to several recent 
publications on critical ischaemia, it appears that this 
patient group can be sub-divided into low and high 
risk groups with respect o outcome. Comment can 
then be made on the natural history of patients with 
critical ischaemia who do not receive revascularisation 
procedures. For those in the lower risk group, the 1- 
year actual imb salvage of 27% is considerably better 
than that of 5% for the higher risk group. 
For surviving patients in the lower risk group, 100% 
cumulative patency is equivalent to only 64% res- 
olution of symptoms at 1 year (i.e. 36% of surviving 
patients would have benefited from conservative treat- 
ment, Fig. 2). 
The limb outcome following intervention is different 
for patients in the high risk group. Here, 100% cumu- 
lative patency is equivalent to 93% limb salvage at 1 
year (ie 93% of survivors have benefited from surgery 
at 1 year). For this group, intervention is usually 
essential for limb viability to be maintained. There is 
no evidence that the use of pharmacotherapy, s m- 
pathectomy or spinal cord stimulation can improve 
limb salvage for these patients. There are, therefore, a 
group of patients with critical ischaemia (tissue 
loss-t-an ankle pressure of <40 mmHg) in whom sur- 
gical/radiological intervention appears to be virtually 
imperative to save the limb. There is a less severely 
affected group for whom we suggest he term sub- 
critical ischaemia (tissues intact and an ankle pressure 
of >40 mmHg) in whom limb loss does not appear 
to be inevitable and pharmacotherapy and medical 
treatment may buy sufficient time for the crisis to pass. 
Pharmacotherapy trials confined to patients in this 
second group are likely to be more valid, as limbs 
unsalvageable by drugs alone have been removed 
from the study. 
In conclusion, we would suggest separation into 
"subcritical" and "critical" when studying patients 
with leg ischaemia. Only by appreciating the different 
natural histories of rest pain and tissue loss can we 
assess accurately the beneficial results of re- 
vascularisation procedures for critical ischaemia. We 
recommend that future reports hould measure results 
against he predicted outcomes, if the true effects of 
intervention are to be fully appreciated. 
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